British Journal of Cancer - Table of Contents alert Volume 106 Issue 6

TABLE OF CONTENTS Volume 106, Issue 6 (1021-1248) Published online 13 March 2012 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics and Genomics Letters to the Editor Corrigendum Also new today Advance online publication Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Increasing the visibility of your research..BJC OPEN Authors may choose to have their original research article made open access on publication (by paying a one off fee) under BJC OPEN. Visit www.bjcancer.com for more information.   Minireview Top Increasing response rates from physicians in oncology research: a structured literature review and data from a recent physician survey Y Martins, R I Lederman, C L Lowenstein, S Joffe, B A Neville, B T Hastings and G A Abel Br J Cancer 2012 106: 1021-1026; advance online publication, February 28, 2012; 10.1038/bjc.2012.28 Abstract | Full Text Clinical Studies Top First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial Ó Arrieta, L A Medina, E Estrada-Lobato, N Hernández-Pedro, G Villanueva-Rodríguez, L Martínez-Barrera, E O Macedo, V López-Rodríguez, D Motola-Kuba and J F Corona-Cruz Br J Cancer 2012 106: 1027-1032; advance online publication, February 21, 2012; 10.1038/bjc.2012.44 Abstract | Full Text Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer J Harder, G Ihorst, V Heinemann, R Hofheinz, M Moehler, P Buechler, G Kloeppel, C Röcken, M Bitzer, S Boeck, E Endlicher, A Reinacher-Schick, C Schmoor and M Geissler Br J Cancer 2012 106: 1033-1038; advance online publication, February 28, 2012; 10.1038/bjc.2012.18 Abstract | Full Text Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum D H Yoon, M-H Ryu, Y S Park, H J Lee, C Lee, B-Y Ryoo, J-L Lee, H-M Chang, T W Kim and Y-K Kang Br J Cancer 2012 106: 1039-1044; advance online publication, February 16, 2012; 10.1038/bjc.2012.47 Abstract | Full Text Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis H Verry, S J Lord, A Martin, G Gill, C K Lee, K Howard, N Wetzig and J Simes Br J Cancer 2012 106: 1045-1052; 10.1038/bjc.2012.62 Abstract | Full Text Making hard choices easier: a prospective, multicentre study to assess the efficacy of a fertility-related decision aid in young women with early-stage breast cancer M Peate, B Meiser, B C Cheah, C Saunders, P Butow, B Thewes, R Hart, K-A Phillips, M Hickey and M Friedlander Br J Cancer 2012 106: 1053-1061; 10.1038/bjc.2012.61 Abstract | Full Text Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation L J Fallowfield, L S Kilburn, C Langridge, C F Snowdon, J M Bliss and R C Coombes on behalf of the IES Trial Steering Committee Br J Cancer 2012 106: 1062-1067; advance online publication, February 21, 2012; 10.1038/bjc.2012.43 Abstract | Full Text Variation in advanced stage at diagnosis of lung and female breast cancer in an English region 2006–2009 G Lyratzopoulos, G A Abel, J M Barbiere, C H Brown, B A Rous and D C Greenberg Br J Cancer 2012 106: 1068-1075; advance online publication, March 1, 2012; 10.1038/bjc.2012.30 Abstract | Full Text A web-based prognostic tool for extremity and trunk wall soft tissue sarcomas and its external validation M Sampo, M Tarkkanen, E Tukiainen, P Popov, P Gustafson, M Lundin, T Böhling, C Blomqvist and J Lundin Br J Cancer 2012 106: 1076-1082; advance online publication, February 21, 2012; 10.1038/bjc.2012.48 Abstract | Full Text Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram D R Yates, V Hupertan, P Colin, A Ouzzane, A Descazeaud, J A Long, G Pignot, S Crouzet, F Rozet, Y Neuzillet, M Soulie, T Bodin, A Valeri, O Cussenot and M Rouprêt for the French collaborative national database on UUT-UC Br J Cancer 2012 106: 1083-1088; advance online publication, February 28, 2012; 10.1038/bjc.2012.64 Abstract | Full Text Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia R Agarwal, V Harding, D Short, R A Fisher, N J Sebire, R Harvey, D Patel, P M Savage, A K P Lim and M J Seckl Br J Cancer 2012 106: 1089-1094; advance online publication, February 28, 2012; 10.1038/bjc.2012.65 Abstract | Full Text Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort J Cuzick, D M Berney, G Fisher, D Mesher, H Møller, J E Reid, M Perry, J Park, A Younus, A Gutin, C S Foster, P Scardino, J S Lanchbury and S Stone on behalf of the Transatlantic Prostate Group Br J Cancer 2012 106: 1095-1099; advance online publication, February 23, 2012; 10.1038/bjc.2012.39 Abstract | Full Text The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers A J Atherly and D R Camidge Br J Cancer 2012 106: 1100-1106; advance online publication, February 28, 2012; 10.1038/bjc.2012.60 Abstract | Full Text Translational Therapeutics Top A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes B Dutta, L Pusztai, Y Qi, F André, V Lazar, G Bianchini, N Ueno, R Agarwal, B Wang, C Y Shiang, G N Hortobagyi, G B Mills, W F Symmans and G Balázsi Br J Cancer 2012 106: 1107-1116; advance online publication, February 16, 2012; 10.1038/bjc.2011.584 Abstract | Full Text Phenformin as prophylaxis and therapy in breast cancer xenografts M V C L Appleyard, K E Murray, P J Coates, S Wullschleger, S E Bray, N M Kernohan, S Fleming, D R Alessi and A M Thompson Br J Cancer 2012 106: 1117-1122; advance online publication, February 23, 2012; 10.1038/bjc.2012.56 Abstract | Full Text The ganglioside antigen GD2 is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting S Kailayangiri, B Altvater, J Meltzer, S Pscherer, A Luecke, C Dierkes, U Titze, K Leuchte, S Landmeier, M Hotfilder, U Dirksen, J Hardes, G Gosheger, H Juergens and C Rossig Br J Cancer 2012 106: 1123-1133; advance online publication, February 28, 2012; 10.1038/bjc.2012.57 Abstract | Full Text Dissection of stromal and cancer cell-derived signals in melanoma xenografts before and after treatment with DMXAA K Henare, L Wang, L-Cs Wang, L Thomsen, S Tijono, C-Jj Chen, S Winkler, P R Dunbar, C Print and L-M Ching Br J Cancer 2012 106: 1134-1147; 10.1038/bjc.2012.63 Abstract | Full Text Molecular Diagnostics Top Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells N Kuzumaki, A Suzuki, M Narita, T Hosoya, A Nagasawa, S Imai, K Yamamizu, H Morita, H Nagase, Y Okada, H J Okano, J K Yamashita, H Okano, T Suzuki and M Narita Br J Cancer 2012 106: 1148-1152; advance online publication, February 16, 2012; 10.1038/bjc.2011.574 Abstract | Full Text Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide R J Young, A W Tin, N J Brown, M Jitlal, S M Lee and P J Woll Br J Cancer 2012 106: 1153-1159; advance online publication, February 21, 2012; 10.1038/bjc.2012.50 Abstract | Full Text HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ E Rakovitch, S Nofech-Mozes, W Hanna, S Narod, D Thiruchelvam, R Saskin, J Spayne, C Taylor and L Paszat Br J Cancer 2012 106: 1160-1165; advance online publication, February 23, 2012; 10.1038/bjc.2012.41 Abstract | Full Text No evidence for the involvement of XMRV or MCV in the pathogenesis of breast cancer G Khan, P S Philip, M Naase and K M I Al Zarouni Br J Cancer 2012 106: 1166-1170; advance online publication, February 16, 2012; 10.1038/bjc.2012.51 Abstract | Full Text Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study S Thomas, C Pütter, S Weber, N Bornfeld, D R Lohmann and M Zeschnigk Br J Cancer 2012 106: 1171-1176; advance online publication, February 21, 2012; 10.1038/bjc.2012.54 Abstract | Full Text Hedgehog pathway activation in human transitional cell carcinoma of the bladder G Pignot, A Vieillefond, S Vacher, M Zerbib, B Debre, R Lidereau, D Amsellem-Ouazana and I Bieche Br J Cancer 2012 106: 1177-1186; advance online publication, February 23, 2012; 10.1038/bjc.2012.55 Abstract | Full Text The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder T Qayyum, G Fyffe, M Duncan, P A McArdle, M Hilmy, C Orange, G Halbert, M Seywright, P G Horgan, M A Underwood and J Edwards Br J Cancer 2012 106: 1187-1195; advance online publication, February 21, 2012; 10.1038/bjc.2012.52 Abstract | Full Text Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway S Maseki, K Ijichi, H Tanaka, M Fujii, Y Hasegawa, T Ogawa, S Murakami, E Kondo and H Nakanishi Br J Cancer 2012 106: 1196-1204; advance online publication, February 7, 2012; 10.1038/bjc.2012.24 Abstract | Full Text Creation of immortalised epithelial cells from ovarian endometrioma Y Bono, S Kyo, M Takakura, Y Maida, Y Mizumoto, M Nakamura, K Nomura, T Kiyono and M Inoue Br J Cancer 2012 106: 1205-1213; advance online publication, February 21, 2012; 10.1038/bjc.2012.26 Abstract | Full Text Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells K Yamamoto, N Ohga, Y Hida, N Maishi, T Kawamoto, K Kitayama, K Akiyama, T Osawa, M Kondoh, K Matsuda, Y Onodera, M Fujie, K Kaga, S Hirano, N Shinohara, M Shindoh and K Hida Br J Cancer 2012 106: 1214-1223; advance online publication, February 28, 2012; 10.1038/bjc.2012.59 Abstract | Full Text Genetics and Genomics Top Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria E A Roundhill and S A Burchill Br J Cancer 2012 106: 1224-1233; advance online publication, February 21, 2012; 10.1038/bjc.2012.40 Abstract | Full Text BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years L Robertson, H Hanson, S Seal, M Warren-Perry, D Hughes, I Howell, C Turnbull, R Houlston, S Shanley, S Butler, D G Evans, G Ross, D Eccles, A Tutt and N Rahman TNT Trial TMG, BCSC (UK) Br J Cancer 2012 106: 1234-1238; advance online publication, February 14, 2012; 10.1038/bjc.2012.31 Abstract | Full Text Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial A Tikidzhieva, A Benner, S Michel, A Formentini, K-H Link, W Dippold, M von Knebel Doeberitz, M Kornmann and M Kloor Br J Cancer 2012 106: 1239-1245; advance online publication, February 21, 2012; 10.1038/bjc.2012.53 Abstract | Full Text Letters to the Editor Top Severe toxicity caused by sorafenib in hepatocellular carcinoma match the data from renal cell carcinoma A Lamarca, J Feliu and J Barriuso Br J Cancer 2012 106: 1246; advance online publication, January 31, 2012; 10.1038/bjc.2012.25 Full Text Adjuvant! Online or comprehensive geriatric assessment for women over 70 years with primary breast cancer? S Monfardini, U Basso, P Fiduccia, D Crivellari, A M Molino and C Falci Br J Cancer 2012 106: 1247; advance online publication, February 16, 2012; 10.1038/bjc.2012.29 Full Text Corrigendum Top Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation C Boykin, G Zhang, Y-H Chen, R-W Zhang, X-E Fan, W-M Yang and Q Lu Br J Cancer 2012 106: 1248; 10.1038/bjc.2012.77 Full Text Advertisement Ensure your access to British Journal of Cancer If you are unable to access the articles in this Table of Contents e-alert, your library may not subscribe to this journal. Our online recommendation form is a simple way to make your librarian aware that this journal is valuable to your research. Recommend now at http://www.nature.com/librec/svc/request/makeCommRequest?id=2.   Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.